AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

LENALIDOMIDE

105 registrations across 8 African markets— 72 active

Markets with LENALIDOMIDE

🇿🇦South Africa
40 registrations
15 active
🇺🇬Uganda
16 registrations
16 active
🇿🇼Zimbabwe
12 registrations
12 active
🇹🇿Tanzania
12 registrations
12 active
🇹🇳Tunisia
8 registrations
0 active
🇰🇪Kenya
7 registrations
7 active
🇬🇭Ghana
6 registrations
6 active
🇲🇦Morocco
4 registrations
4 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
GLENALIDOM 5
CAPSULE; ORAL
🇿🇼ZimbabweGLENMARK PHARMACEUTICAL LIMITEDactiveMar 2031
GLENALIDOM 25
CAPSULE; ORAL
🇿🇼ZimbabweGLENMARK PHARMACEUTICAL LIMITEDactiveMar 2031
GLENALIDOM 15
CAPSULE; ORAL
🇿🇼ZimbabweGLENMARK PHARMACEUTICAL LIMITEDactiveMar 2031
LENALIDOMIDE 10MG
CAPSULE; ORAL
🇿🇼ZimbabweGLENMARK PHARMACEUTICAL LIMITEDactiveMar 2031
LINADEX 25
Capsule
🇰🇪KenyaHetero Labs LimitedactiveOct 2030
Lenangio 5
Capsule
🇰🇪KenyaDR. REDDY’S LABORATORIES LIMITEDactiveMay 2030
ADCCLENA 15MG TABLETS🇬🇭Ghana—activeMay 2030
ADCCLENA 5MG TABLETS🇬🇭Ghana—activeMay 2030
ADCCLENA 5MG TABLETS🇬🇭Ghana—activeMay 2030
ADCCLENA 15MG TABLETS🇬🇭Ghana—activeMay 2030
LINADEX 10
Capsule
🇰🇪KenyaHetero Labs LimitedactiveMay 2030
ADCCLENA 10MG TABLETS🇬🇭Ghana—activeMay 2030
ADCCLENA 10MG TABLETS🇬🇭Ghana—activeMay 2030
Lenangio 10
Capsule
🇰🇪KenyaDR. REDDY’S LABORATORIES LIMITEDactiveDec 2029
Lenangio 25
Capsule
🇰🇪KenyaDR. REDDY’S LABORATORIES LIMITEDactiveDec 2029
LENOSIDE 15
CAPSULE; ORAL
🇿🇼ZimbabweCIPLA LTDactiveJul 2029
LENOSIDE 25
CAPSULE; ORAL
🇿🇼ZimbabweCIPLA LTDactiveJul 2029
LENOSIDE 10
CAPSULE; ORAL
🇿🇼ZimbabweCIPLA LTDactiveJul 2029
LEDOBOOK 10
Capsule
🇰🇪KenyaAUROBINDO PHARMA LIMITEDactiveApr 2029
LEDOBOOK 25
Capsule
🇰🇪KenyaAUROBINDO PHARMA LTD.,activeApr 2029
CANCALID 2,5 mg🇿🇦South AfricaAurogen South Africa (Pty) LtdunknownAug 2028
DATRENAL 7,5 mg🇿🇦South AfricaAurogen South Africa (Pty) LtdunknownAug 2028
DATRENAL 10 mg🇿🇦South AfricaAurogen South Africa (Pty) LtdunknownAug 2028
DATRENAL 15 mg🇿🇦South AfricaAurogen South Africa (Pty) LtdunknownAug 2028
DATRENAL 20 mg🇿🇦South AfricaAurogen South Africa (Pty) LtdunknownAug 2028
DATRENAL 25 mg🇿🇦South AfricaAurogen South Africa (Pty) LtdunknownAug 2028
CANCALID 5 mg🇿🇦South AfricaAurogen South Africa (Pty) LtdunknownAug 2028
CANCALID 7,5 mg🇿🇦South AfricaAurogen South Africa (Pty) LtdunknownAug 2028
CANCALID 10 mg🇿🇦South AfricaAurogen South Africa (Pty) LtdunknownAug 2028
CANCALID 25 mg🇿🇦South AfricaAurogen South Africa (Pty) LtdunknownAug 2028
DATRENAL 5 mg🇿🇦South AfricaAurogen South Africa (Pty) LtdunknownAug 2028
CANCALID 20 mg🇿🇦South AfricaAurogen South Africa (Pty) LtdunknownAug 2028
CANCALID 15 mg🇿🇦South AfricaAurogen South Africa (Pty) LtdunknownAug 2028
DATRENAL 2,5 mg🇿🇦South AfricaAurogen South Africa (Pty) LtdunknownAug 2028
ADDCLENA 15
CAPSULE
🇿🇼ZimbabweMYLAN LABORATORIES LIMITED [OTL]activeDec 2027
MYELOPAST 25
CAPSULE; ORAL
🇿🇼ZimbabweMSN LABORATORIES PRIVATE LIMITEDactiveDec 2027
ADDCLENA 5
CAPSULE
🇿🇼ZimbabweMYLAN LABORATORIES LIMITED [OTL]activeDec 2027
ADDCLENA 10
CAPSULE
🇿🇼ZimbabweMYLAN LABORATORIES LIMITED [OTL]activeDec 2027
MYELOPAST 10
CAPSULE; ORAL
🇿🇼ZimbabweMSN LABORATORIES PRIVATE LIMITEDactiveDec 2027
Adco Lenalidomide 2.5 mg🇿🇦South AfricaAdcock Ingram LimitedsuspendedMar 2025
Adco Lenalidomide 25 mg🇿🇦South AfricaAdcock Ingram LimitedsuspendedMar 2025
Adco Lenalidomide 7.5 mg🇿🇦South AfricaAdcock Ingram LimitedsuspendedMar 2025
Adco Lenalidomide 5 mg🇿🇦South AfricaAdcock Ingram LimitedsuspendedMar 2025
Adco Lenalidomide 20 mg🇿🇦South AfricaAdcock Ingram LimitedsuspendedMar 2025
Adco Lenalidomide 10 mg🇿🇦South AfricaAdcock Ingram LimitedsuspendedMar 2025
Adco Lenalidomide 15 mg🇿🇦South AfricaAdcock Ingram LimitedsuspendedMar 2025
REVLIMID 10 mg🇿🇦South AfricaKey Oncologics (Pty) LtdsuspendedJan 2024
REVLIMID 15 mg🇿🇦South AfricaKey Oncologics (Pty) LtdsuspendedJan 2023
REVLIMID 5 mg🇿🇦South AfricaKey Oncologics (Pty) LtdsuspendedJan 2023
REVLIMID 25 mg🇿🇦South AfricaKey Oncologics (Pty) LtdsuspendedJan 2023

Showing 50 of 105 registrations. Sign up free to search and export all.

LENALIDOMIDE in Africa — Regulatory Overview

LENALIDOMIDE is registered across 8 African markets with 105 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Uganda, Zimbabwe, Tanzania and 4 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 105 registrations, 72 (69%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.